Registro:

Referencias:

• Ng, W.F., Bowman, S.J., Griffiths, B., United Kingdom Primary Sjögren's Syndrome Registry - a united effort to tackle an orphan rheumatic disease (2011) Rheumatology, 50, pp. 32-39. , on behalf of the UKPSSR study group
• Gabriel, S.E., Michaud, K., Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases (2009) Arthritis Res Ther, 11, p. 229. , doi:10.1186/ ar2669. Available at:
• Fox, R.I., Sjögren's syndrome (2005) Lancet, 366, pp. 321-331
• Mavragani, C.P., Moutsopoulos, N.M., Moutsopoulos, H.M., The management of Sjögren's syndrome (2006) Nat Clin Pract Rheumatol, 2, pp. 252-2261
• Manoussakis, M.N., Moutsopoulos, H.M., Sjögren's syndrome: autoimmune epithelitis (2000) Ballière's Clin Rheumatol, 14, pp. 73-95
• Konttinen, Y., Porola, P., Konttinen, L., Laine, M., Poduval, P., Immunohistopathology of Sjögren's syndrome (2006) Autoimmun Rev, 6, pp. 16-20
• Törnwall, J., Konttinen, Y.T., Tuominen, R.K., Törnwall, M., Protein kinase C expression in salivary gland acinar epithelial cells in Sjögren's syndrome (1997) Lancet, 349, pp. 1814-1851
• Steinfeld, S.D., Appelboom, T., Delporte, C., Treatment with infliximab restores normal aquaporin 5 distribution in minor salivary glands of patients with Sjögren's syndrome (2002) Arthritis Rheum, 46, pp. 2249-2251
• van Blokland, S.C., Versnel, M.A., Pathogenesis of Sögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy (2002) Clin Immunol, 103, pp. 111-124
• Lee, B.H., Tudares, M.A., Nguyen, C.Q., Sjögren's syndrome: an old tale with a new twist (2009) Arch Immunol Ther Exp (Warsz), 57, pp. 57-66
• Delaleu, N., Immervoll, H., Cornelius, J., Jonsson, R., Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations (2008) Arthritis Res Ther, 10, pp. R22
• Rosignoli, F., Roca, V., Meiss, R., Leceta, J., Gomariz, R.P., Pérez Leirós, C., Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis (2005) Clin Exp Immunol, 142, pp. 411-418
• Jonsson, M.V., Delaleu, N., Brokstad, K.A., Berggreen, E., Skarstein, K., Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland (2006) Arthritis Rheum, 54, pp. 2300-2305
• Berggreen, E., Nylokken, K., Delaleu, N., Hajdaragic-Ibricevic, H., Jonsson, M.V., Impaired vascular responses to parasympathetic nerve stimulation and muscarinic receptor activation in the submandibular gland in non-obese diabetic mice (2009) Arthritis Res Ther, 11, pp. R18
• Rosignoli, F., Roca, V., Meiss, R., Pregi, N., Pérez Leirós, C., Inhibition of calcium-calmodulin kinase restores nitric oxide production and signaling in submandibular glands of a mouse model of salivary dysfunction (2004) Br J Pharmacol, 143, pp. 1058-1065
• Calafat, M., Larocca, L., Roca, V., Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands (2009) Arthritis Res Ther, 11, pp. R53. , doi:10.1186/ar2671. Available at:
• Ekström, J., Autonomic control of salivary secretion (1989) Proc Finn Dent Soc, 85, pp. 323-331
• Månsson, B., Nilsson, B.O., Ekström, J., Effects of repeated infusions of substance P and vasoactive intestinal peptide on the weights of salivary glands subjected to atrophying influences in rats (1990) Br J Pharmacol, 101, pp. 853-858
• Gomariz, R.P., Juarranz, Y., Abad, C., Arranz, A., Leceta, J., Martinez, C., VIP-PACAP system in immunity: new insights for multitarget therapy (2006) Ann NY Acad Sci, 1070, pp. 51-74
• Gonzalez-Rey, E., Ganea, D., Delgado, M., Neuropeptides: keeping the balance between pathogen immunity and immune tolerance (2010) Curr Opin Pharmacol, 10, pp. 473-481
• Gomariz, R.P., Gutiérrez-Cañas, I., Arranz, A., Peptides targeting Toll-like receptor signalling pathways for novel immune therapeutics (2010) Curr Pharm Des, 16, pp. 1063-1080
• Rosignoli, F., Torroba, M., Juarranz, Y., VIP and tolerance induction in autoimmunity (2006) Ann NY Acad Sci, 1070, pp. 525-530
• Lodde, B.M., Mineshiba, F., Wang, J., Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjögren's syndrome (2006) Ann Rheum Dis, 65, pp. 195-200
• Larocca, L., Hauk, V., Calafat, M., Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice (2011) Mol Cell Endocrinol, 333, pp. 112-118
• Larocca, L., Calafat, M., Roca, V., Franchi, A.M., Pérez Leirós, C., VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages (2007) Int Immunopharmacol, 7, pp. 1343-1349
• Roca, V., Larocca, L., Calafat, M., Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of NOD mice (2006) Reproduction, 132, pp. 931-938
• Jimeno, R., Gomariz, R.P., Gutierrez-Cañas, I., Martínez, C., Juarranz, Y., Leceta, J., New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes (2010) Immunol Cell Biol, 88, pp. 734-745
• Dale, E., Davis, M., Faustman, D.L., A role for transcription factor NF-kB in autoimmunity: possible interactions of genes, sex and the immune response (2006) Adv Physiol Educ, 30, pp. 152-158
• Kim, M.J., Joo, K.M., Chung, Y.H., Vasoactive intestinal peptide (VIP) and VIP mRNA decrease in the cerebral cortex of nNOS knock-out(-/-) mice (2003) Brain Res, 978, pp. 233-240
• Strietzel, F.P., Lafaurie, G.I., Mendoza, G.R., Efficacy and safety of an intraoral electrostimulation device for xerostomia relief: a multicenter, randomized trial (2011) Arthritis Rheum, 63, pp. 180-190
• Zha, J., Harada, H., Yang, E., Jockel, J., Korsmeyer, S.J., Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) (1996) Cell, 87, pp. 619-628
• Kong, L., Ogawa, N., McGuff, H.S., Bcl-2 family expression in salivary glands from patients with primary Sjögren's syndrome: involvement of Bax in salivary gland destruction (1998) Clin Immunol Immunopathol, 88, pp. 133-141
• Kong, L., Ogawa, N., Nakabayashi, T., Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome (1997) Arthritis Rheum, 40, pp. 87-97
• Kong, L., Robinson, C.P., Peck, A.B., Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-SCID mice (1998) Clin Exp Rheumatol, 16, pp. 675-681
• Nguyen, C.Q., Cornelius, J.G., Cooper, L., Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy (2008) Arthritis Res Ther, 10, pp. R137. , doi:10.1186/ar2560. Available at:
• Vosters, J.L., Yin, H., Roescher, N., Kok, M.R., Tak, P.P., Chiorini, J.A., Local expression of tumor necrosis factor-receptor 1: immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome (2009) Arthritis Res Ther, 11, pp. R189
• Krause, S., Kuckelkorn, U., Dörner, T., Burmester, G.R., Feist, E., Kloetzel, P.M., Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders (2006) Ann Rheum Dis, 65, pp. 1021-1027
• Mosser, D.M., Edwards, J.P., Exploring the full spectrum of macrophage activation (2008) Nat Rev Immunol, 8, pp. 958-969
• O'Brien, B.A., Huang, Y., Geng, X., Dutz, J.P., Finegood, D.T., Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced (2002) Diabetes, 51, pp. 2481-2488
• Stoffels, K., Overbergh, L., Giulietti, A., NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells (2004) J Autoimmun, 23, pp. 9-15
• Marée, A.F., Komba, M., Finegood, D.T., Edelstein-Keshet, L., A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice (2008) J Appl Physiol, 104, pp. 157-169

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------